Jiangsu Recbio Technology Co. Ltd. released phase II data showing its recombinant two-component COVID-19 vaccine Recov appeared more effective than Comirnaty (tozinameran), the mRNA vaccine developed by Biontech SE and Pfizer Inc., as a booster for users of inactivated vaccines.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Genentech, Intercept, Ipsen, Janux, Kaken, Leo, Mediwound, Mindrank AI, Neuren, Neurocrine, Nova Mentis, Regeneron, Revive, Springworks, Valneva, Zielbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acasti, Bioxytran, Can-Fite, Clene, PDS.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acer, Adaptimmune, Antengene, Basilea, Biogen, Brainstorm, Celltrion, Coherus, Daiichi Sankyo, DBV, Deka, Disc, Eisai, Elpiscience, Immutep, Junshi, Kite, Relief.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Applied Molecular Transport, Atai, Biontech, Cellectis, Dilafor, Immunis, Jiangsu Recbio, Karolinska, Kures, Nanobiotix, Neuren.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abivax, Actinogen, ADC, Affimed, Akebia, Aldeyra, Alnylam, Alvotech, Aquestive, Astrazeneca, Benevolentai, Edesa, Genentech, Genmab, Gilead, Gradalis, Iaso, Innocare, Merck, Mirati, Onkyo, Outlook, Pfizer, Radius, Regenxbio, Sanofi, Sobi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aerami, Akero, Armata, Astrazeneca, Bavarian Nordic, Beckley, Biontech, Bridgebio, Chemomab, Contrafect, Exelixis, Imago, Imbrium, Kempharm, Lexicon, Melt, Minovia, Mirata, Osivax, RQ, Sirnaomics, Small, Sosei, Vir, Viridian, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altimmune, Arcus, Athenex, Biolinerx, Erasca, Journey Medical, Magenta, Nanology, Nykode, Oncotherapeutics, Quantum Leap, Regimmune, Satsuma, Simcere, Takeda, Ultimovacs, Verona.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amgen, Angiocrine, Arrowhead, Carrick, Catalyst, Eisai, Menarini, Merck, Paratek, Pfizer, Royalty.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Alexbio, Amicus, Apellis, Boehringer Ingelheim, CSL Behring, Eli Lilly, Jacobio, Miromatrix, Moderna, Ocugen, Roche, Regeneron, Sanofi, Uniqure, Y-Mabs.